4//SEC Filing
CUMMING JOHN W 4
Accession 0000899243-21-027183
CIK 0001492674other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:00 PM ET
Size
5.1 KB
Accession
0000899243-21-027183
Insider Transaction Report
Form 4
CUMMING JOHN W
Director
Transactions
- Sale
Common Stock
2021-07-01$1.16/sh−18,182$21,091→ 50,852 total
Footnotes (2)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021, to cover payment of tax liability incident to the vesting of restricted stock units.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.16 to $1.19. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001181189
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:00 PM ET
- Size
- 5.1 KB